About ActiPatch®
Everyday pain relief, without the pills
ActiPatch® is a self-contained, FDA-cleared, over-the-counter wearable for adjunctive treatment of musculoskeletal pain. Electrome markets and sells it in the U.S. under an exclusive license from its manufacturer, BioElectronics Corporation.
What ActiPatch® is
A small wearable that delivers pulsed shortwave therapy (PSWT). It works on its own, alongside the care you already use.
FDA cleared
Cleared for over-the-counter (OTC) use
Drug-free
Noninvasive, nonsystemic therapy
Self-contained
No app, pairing, or subscription
Wearable
Used at home, day or night
The team
Physicians, scientists, and operators at Electrome, the company that brings ActiPatch® to U.S. customers.
Erik A. Nilsen, PhD
Co-Founder, CEO & CTO
Erik A. Nilsen, PhD, is a physicist and electrical engineer with a PhD in applied physics and advanced degrees in electrical engineering and mathematics.
Nev Zubcevik, D.O.
Co-Founder & CMO
Dr. Nev Zubcevik is a board-certified physician and former Harvard Medical School faculty member and Medical Director at Spaulding Rehabilitation Hospital, with deep expertise in musculoskeletal medicine, traumatic brain injury, concussion, and non-pharmacologic pain management.
Danny Rubenstein
Chief Commercialization Officer
Danny Rubenstein is a commercial operator and strategic advisor with 40+ years of experience across consumer products, food, and emerging businesses.
Joe Oliveri
Director, Sports & Fitness Partnerships
Joe Oliveri leads Electrome's sports and fitness channel end to end, with a primary focus on golf pro shops and golf retail, plus fitness centers, retail chains, distributors, agency partnerships, and military and public safety buyers.
Samir S. Awad, MD
Medical Director
Bioengineering graduate of the University of Pennsylvania with expertise in electrophysiology, then medicine and surgical critical care training (University of Michigan).
Shari O'Connor, PharmD, MBA
Scientific Advisor, Clinical Marketing & Sales Development
Shari O'Connor is a neuroimmunology expert with 30+ years advancing brain and immune-system therapies, with board-level credentials in Neurology, Immunology, Nutrition, and Pharmacogenomics.
Wanni Davis, PhD, MBA
Licensing Advisor
Wanni Davis is a biotech strategist with 15+ years spanning translational science, venture development, and commercialization.
Jennifer Libby, MSW, LCSW
Advisor
Research at Electrome
Today, MATRIX Discovery, Electrome's operating internal AI-native R&D software, pairs evidence review, candidate ranking, and mathematical signal modeling with controlled laboratory validation under a human scientific release gate. It does not diagnose, monitor, or treat a person.
The mat-based MATRIX System and its proposed Scan → Diagnose → Compute → Treat → Measure → Adapt → Treat again loop are future research, not capabilities available today. Diagnose is a future research goal, not an existing diagnostic capability. The System is not FDA cleared, not an approved therapy, and not available; it would advance only through validation, human review, and an appropriate regulatory pathway.
Work with us
Careers, partnerships, and investor information.